Recent studies have revealed that OLIG2 and ASCL1 bind to each other’s genomic loci and downstream targets, cooperatively regulating tumor cell plasticity and heterogeneity [49], suggesting that transcription factor gene combinations—rather than individual factors—may drive tumor progression. The gene discussed is OLIG2; the disease is neoplasm.